entertainment -WSS

entertainment

author：Wikipedia 2025-09-04 22:01:34 - browse：6645

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

“I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Histogen: Failed biotech offers rare public look inside

explore

hotspot

WSS

Crinetics acromegaly drug succeeds in late

Why Novartis is changing the name of its research labs

Ethical issues complicate the benefits of medical crowdfunding

Ethical issues complicate the benefits of medical crowdfunding

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Bristol 'take

knowledge

entertainment

explore

What does generative AI mean for health care? We asked experts

How to fix cancer clinical trials' diversity problem

Walensky prepares to leave CDC — and Congress — behind

Bristol 'take

How one medical school became remarkably diverse

Stem cell treatment guidelines are released by FDA

Medical leaders decry Supreme Court decision on affirmative action

Bristol 'take

Medicare proposal to cover medical devices draws a mixed reaction

Colorectal cancer study finds potential in overlooked immune cell

entertainment

Listen: Biogen's potential pivot, & Illumina's next chapter

What to expect at HLTH 2023, the health care industry conference

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Covid hospitalizations on the rise, Humana says

Weighted lottery helped low

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

hotspot

hotspot

explore

hotspot